Search Results - "Dombernowsky, P." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate

by Dombernowsky, P, Smith, I, Falkson, G, Leonard, R, Panasci, L, Bellmunt, J, Bezwoda, W, Gardin, G, Gudgeon, A, Morgan, M, Fornasiero, A, Hoffmann, W, Michel, J, Hatschek, T, Tjabbes, T, Chaudri, H A, Hornberger, U, Trunet, P F
Published in Journal of clinical oncology (01.02.1998)

Get more information

Journal Article

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer

by Ryberg, M, Nielsen, D, Skovsgaard, T, Hansen, J, Jensen, B V, Dombernowsky, P
Published in Journal of clinical oncology (01.11.1998)

Get more information

Journal Article

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

by van Oosterom, A.T, Mouridsen, H.T, Nielsen, O.S, Dombernowsky, P, Krzemieniecki, K, Judson, I, Svancarova, L, Spooner, D, Hermans, C, Van Glabbeke, M, Verweij, J
Published in European journal of cancer (1990) (01.12.2002)

Get full text

Journal Article

Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA

Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA

by Sölétormos, G., Nielsen, D., Schiøler, V., Mouridsen, H., Dombernowsky, P.
Published in European journal of cancer (1990) (01.03.2004)

Get full text

Journal Article

Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic

Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic

by Gehl, J., Boesgaard, M., Paaske, T., Jensen, B. Vittrup, Dombernowsky, P.
Published in Annals of oncology (01.09.1996)

Get full text

Journal Article

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

by TUXEN, M. K, SÖLETORMOS, G, DOMBERNOWSKY, P
Published in British journal of cancer (18.05.2001)

Get full text

Journal Article

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

by Gianni, L., Dombernowsky, P., Sledge, G., Martin, M., Amadori, D., Arbuck, S. G., Ravdin, P., Brown, M., Messina, M., Tuck, D., Weil, C., Winograd, B.
Published in Annals of oncology (01.08.2001)

Get full text

Journal Article

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients

by Lassen, U, Osterlind, K, Hansen, M, Dombernowsky, P, Bergman, B, Hansen, H H
Published in Journal of clinical oncology (01.05.1995)

Get more information

Journal Article

Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy

Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy

by Ryberg, M., Nielsen, D., Østerlind, K., Skovsgaard, T., Dombernowsky, P.
Published in Annals of oncology (01.01.2001)

Get full text

Journal Article

Ondansetron Plus Metopimazine Compared With Ondansetron Plus Metopimazine Plus Prednisolone as Antiemetic Prophylaxis in Patients Receiving Multiple Cycles of Moderately Emetogenic Chemotherapy

Ondansetron Plus Metopimazine Compared With Ondansetron Plus Metopimazine Plus Prednisolone as Antiemetic Prophylaxis in Patients Receiving Multiple Cycles of Moderately Emetogenic Chemotherapy

by SIGSGAARD, T, HERRSTEDT, J, HANDBERG, J, KJAER, M, DOMBERNOWSKY, P
Published in Journal of clinical oncology (01.04.2001)

Get full text

Journal Article

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

by NIELSEN, O. S, DOMBERNOWSKY, P, TURSZ, T, MOURIDSEN, H, CROWTHER, D, VERWEIJ, J, BUESA, J, STEWARD, W, DAUGAARD, S, VAN GLABBEKE, M, KIRKPATRICK, A
Published in British journal of cancer (01.12.1998)

Get full text

Journal Article

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

by Herrstedt, J, Sigsgaard, T C, Nielsen, H A, Handberg, J, Langer, S W, Ottesen, S, Dombernowsky, P
Published in Supportive care in cancer (01.04.2007)

Get full text

Journal Article

Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis

Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis

by Sørensen, J B, Hansen, H H, Hansen, M, Dombernowsky, P
Published in Journal of clinical oncology (01.09.1988)

Get more information

Journal Article

Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up

Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up

by Tuxen, M. K., SöLétormos, G., Dombernowsky, P.
Published in Scandinavian journal of clinical and laboratory investigation (2002)

Get full text

Journal Article

Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer

Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer

by Dombernowsky, P, Gehl, J, Boesgaard, M, Paaske, T, Jensen, B V
Published in Seminars in oncology (01.10.1996)

Get more information

Journal Article

Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer

Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer

by Herrstedt, J, Sigsgaard, T, Handberg, J, Schousboe, B M, Hansen, M, Dombernowsky, P
Published in Journal of clinical oncology (01.04.1997)

Get more information

Journal Article

Doxorubicin plus paclitaxel in advanced breast cancer

Doxorubicin plus paclitaxel in advanced breast cancer

by Dombernowsky, P, Boesgaard, M, Andersen, E, Jensen, B V
Published in Seminars in oncology (01.10.1997)

Get more information

Journal Article

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

by LASSEN, U. N, ØSTERLIND, K, HIRSCH, F. R, BERGMAN, B, DOMBERNOWSKY, P, HANSEN, H. H
Published in British journal of cancer (01.02.1999)

Get full text

Journal Article

$Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D 2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy$

Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D 2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy

by Sigsgaard, T., Herrstedt, J., Christensen, P., Andersen, O., Dombernowsky, P.
Published in Supportive care in cancer (01.05.2000)

Get full text

Journal Article

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer

by Nielsen, D, Jensen, J B, Dombernowsky, P, Munck, O, Fogh, J, Brynjolf, I, Havsteen, H, Hansen, M
Published in Journal of clinical oncology (01.11.1990)

Get more information

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[13]